147 related articles for article (PubMed ID: 12541044)
1. Micrometastases from HBP malignancies and metastatic cancer.
Hosch SB; Steffani KD; Scheunemann P; Izbicki JR
J Hepatobiliary Pancreat Surg; 2002; 9(5):583-91. PubMed ID: 12541044
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored.
Su D; Yamaguchi K; Tanaka M
Pancreatology; 2005; 5(4-5):316-24; discussion 324. PubMed ID: 15983443
[TBL] [Abstract][Full Text] [Related]
3. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
4. Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Bjørnland K; Flatmark K; Mala T; Mathisen O; Bakka A; Aasen AO; Bergan A; Søreide O; Fodstad O
J Surg Oncol; 2003 Apr; 82(4):224-7. PubMed ID: 12672004
[TBL] [Abstract][Full Text] [Related]
5. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.
Vlems FA; Wobbes T; Punt CJ; Van Muijen GN
Anticancer Res; 2003; 23(1B):523-30. PubMed ID: 12680140
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis.
Koch M; Kienle P; Logan E; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schmidt J; Herfarth C; Weitz J
Ann Surg Oncol; 2007 Feb; 14(2):810-7. PubMed ID: 17103077
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin is a superior marker for detection of micrometastatic biliary tract carcinoma.
Natarajan S; Xu F; Gilchrist K; Weber SM
J Surg Res; 2005 May; 125(1):9-15. PubMed ID: 15836844
[TBL] [Abstract][Full Text] [Related]
8. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
9. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
[TBL] [Abstract][Full Text] [Related]
10. Cancers of the pancreas and hepatobiliary system.
Sauerland C; Engelking C; Wickham R; Pearlstone DB
Semin Oncol Nurs; 2009 Feb; 25(1):76-92. PubMed ID: 19217507
[TBL] [Abstract][Full Text] [Related]
11. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
[TBL] [Abstract][Full Text] [Related]
12. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
13. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
14. Measurement of serum marker for bone metastasis (1-CTP) in hepatobiliary and pancreas malignancies.
Nanashima A; Takeshita H; Tobinaga S; Araki M; Sumida Y; Kunizaki M; Tanaka K; Abo T; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2010; 57(101):694-7. PubMed ID: 21033212
[TBL] [Abstract][Full Text] [Related]
15. [Detection of isolated disseminated tumor cells of colorectal carcinomas in lymph nodes].
Weitz J; Kienle P; Magener A; Willeke F; Lehnert T; Herfarth C; von Knebel Doeberitz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):319-22. PubMed ID: 14518268
[TBL] [Abstract][Full Text] [Related]
16. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in colorectal cancer: detection methods and clinical significance.
Tsouma A; Aggeli C; Pissimissis N; Lembessis P; Zografos GN; Koutsilieris M
Anticancer Res; 2008; 28(6B):3945-60. PubMed ID: 19192655
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated tumour cells in the liver of cancer patients.
Conzelmann M; Linnemann U; Berger MR
Eur J Surg Oncol; 2005 Nov; 31(9):977-85. PubMed ID: 16126360
[TBL] [Abstract][Full Text] [Related]
20. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
